Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction.
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction. J Exp Clin Cancer Res. 2022 Feb 07; 41(1):51.